Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Relay Therapeutics (RLAY) Gross Profit: 2019-2024

Historic Gross Profit for Relay Therapeutics (RLAY) over the last 6 years, with Dec 2024 value amounting to $10.0 million.

  • Relay Therapeutics' Gross Profit was N/A to $677,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $18.4 million, marking a year-over-year change of. This contributed to the annual value of $10.0 million for FY2024, which is 60.83% down from last year.
  • Latest data reveals that Relay Therapeutics reported Gross Profit of $10.0 million as of FY2024, which was down 60.83% from $25.5 million recorded in FY2023.
  • Relay Therapeutics' 5-year Gross Profit high stood at $82.7 million for FY2020, and its period low was $1.4 million during FY2022.
  • In the last 3 years, Relay Therapeutics' Gross Profit had a median value of $10.0 million in 2024 and averaged $12.3 million.
  • Its Gross Profit has fluctuated over the past 5 years, first surged by 142,606.90% in 2020, then slumped by 96.34% in 2021.
  • Relay Therapeutics' Gross Profit (Yearly) stood at $82.7 million in 2020, then crashed by 96.34% to $3.0 million in 2021, then tumbled by 54.41% to $1.4 million in 2022, then skyrocketed by 1,749.82% to $25.5 million in 2023, then plummeted by 60.83% to $10.0 million in 2024.